pmid	doi	year	title	Hugo_Symbol
33611795	10.1002/gcc.22943	2022	MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.	MYB
34573335	10.3390/genes12091355	2022	Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia.	MYB
34601571	10.1182/blood.2021013156	2022	Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.	MYB
35022522	10.1038/s41417-021-00421-6	2022	Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia.	MYB
35091678	10.1038/s41388-021-02162-0	2022	An mRNA expression-based signature for oncogene-induced replication-stress.	MYB
35205272	10.3390/genes13020227	2022	The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.	MYB
36072598	10.3389/fimmu.2022.974088	2022	MiR-150 in HTLV-1 infection and T-cell transformation.	MYB
31885322	10.1080/15384101.2019.1706903	2021	The double dealing of cyclin D1.	MYB
32420699	10.1002/cam4.3136	2021	Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma.	MYB
32701692	10.1097/DAD.0000000000001632	2021	A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.	MYB
32732362	10.3324/haematol.2020.254276	2021	Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1.	MYB
32779388	10.1111/ajco.13406	2021	v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemia.	MYB
32868912	10.1038/s41423-020-00527-1	2021	Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution.	MYB
32878504	10.1080/03630269.2020.1811117	2021	Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions.	MYB
33538126	10.1111/ijlh.13477	2021	Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases.	MYB
33603066	10.1038/s41598-021-83613-2	2021	Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells.	MYB
33884195	10.3892/br.2021.1428	2021	Regulation of gene transcription of B lymphoma Mo-MLV insertion region 1 homolog (Review).	MYB
33930347	10.1016/j.bcp.2021.114576	2021	Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis.	MYB
33971281	10.1016/j.canlet.2021.04.027	2021	Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia.	MYB
34212378	10.1111/bjh.17609	2021	Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocation.	MYB
34535769	10.1038/s41388-021-02012-z	2021	Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.	MYB
34588425	10.1038/s41420-021-00655-1	2021	The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis.	MYB
30038718	10.18632/oncotarget.25707	2020	MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways.	MYB
30112030	10.3892/etm.2018.6230	2020	The clinical significance of Mda-7/IL-24 and C-myb expression in tumor tissues of patients with diffuse large B cell lymphoma.	MYB
30646895	10.1186/s12920-018-0469-0	2020	Regulatory network analysis reveals the oncogenesis roles of feed-forward loops and therapeutic target in T-cell acute lymphoblastic leukemia.	MYB
31218974	10.1017/S0967199419000169	2020	Synergistic effect of basic fibroblast growth factor (bFGF) and epidermal growth factor on derivation of camel (<i>Camelus dromedarius</i>) trophoblast stem cells.	MYB
31557894	10.3390/cancers11101427	2020	FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma.	MYB
31628193	10.1074/jbc.RA119.010144	2020	DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis.	MYB
31648321	10.1182/bloodadvances.2019000404	2020	Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia.	MYB
31719683	10.1038/s41375-019-0628-0	2020	Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma.	MYB
31882553	10.21873/cgp.20169	2020	BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach.	MYB
32526730		2020	T-Cell Acute Lymphoblastic Leukemia: A Cytogenomic Update.	MYB
32565969	10.3892/ol.2020.11583	2020	Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments.	MYB
28394181	10.1080/10428194.2017.1292357	2019	A novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditions.	MYB
28959124		2019	Higher Expression of Activation-induced Cytidine Deaminase Is Significantly Associated with Merkel Cell Polyomavirus-negative Merkel Cell Carcinomas.	MYB
29233926	10.1158/0008-5472.CAN-17-2644	2019	Targeting CDK6 and BCL2 Exploits the MYB Addiction of Ph<sup>+</sup> Acute Lymphoblastic Leukemia.	MYB
29654272	10.1038/s41375-018-0110-4	2019	Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia.	MYB
29666007	10.1016/j.cancergen.2018.02.006	2019	Mutation analysis of therapy-related myeloid neoplasms.	MYB
30031020	10.1016/j.yexmp.2018.07.009	2019	EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.	MYB
30078801	10.11406/rinketsu.59.899	2019	[Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling].	MYB
30289070	10.2174/1566524018666181004121604	2019	Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.	MYB
30308041	10.1371/journal.pone.0205537	2019	NKL homeobox gene activities in B-cell development and lymphomas.	MYB
27307595	10.1158/1078-0432.CCR-15-1739	2018	Dysregulation of c-Myb Pathway by Aberrant Expression of Proto-oncogene MYB Provides the Basis for Malignancy in Adult T-cell Leukemia/lymphoma Cells.	MYB
28331227	10.1038/leu.2017.94	2018	ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.	MYB
28489605	10.18632/oncotarget.17383	2018	Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome.	MYB
29328450	10.3892/mmr.2018.8387	2018	MYBL2 protects against H9c2 injury induced by hypoxia via AKT and NF‑κB pathways.	MYB
29415639	10.1080/10245332.2018.1435046	2018	Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients.	MYB
27150054	10.1016/j.trsl.2016.04.001	2017	ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex.	MYB
27457538	10.1038/leu.2016.170	2017	c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish.	MYB
27607579	10.1038/cddis.2016.267	2017	Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.	MYB
27659822	10.1007/s00381-016-3163-6	2017	An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update.	MYB
28260788	10.1038/leu.2017.75	2017	APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL.	MYB
28270453	10.1182/blood-2016-09-742148	2017	Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.	MYB
28671688	10.1038/ng.3909	2017	The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia.	MYB
28790107	10.1182/blood-2017-03-775536	2017	RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemia.	MYB
29099869	10.1371/journal.ppat.1006708	2017	Selection for avian leukosis virus integration sites determines the clonal progression of B-cell lymphomas.	MYB
25924238	10.18632/oncotarget.3519	2016	Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.	MYB
26060891	10.1080/15548627.2015.1040970	2016	MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals.	MYB
26206799	10.3324/haematol.2015.130179	2016	Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.	MYB
26500265	10.3382/ps/pev289	2016	Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.	MYB
26670384	10.1128/mBio.01863-15	2016	Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas.	MYB
26862517	10.22074/cellj.2016.3808	2016	MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin.	MYB
27456405	10.3109/10428198909042456	2016	Constitutive Expression of Multiple Cellular Oncogenes in Acute Myeloid Leukemia Cells.	MYB
27458673	10.3109/10428199109068065	2016	C-Jun is Induced to High Continuous Expression During Differentiation of Hematopoietic Cells and is Regulated Independently from C-Fos.	MYB
25193702	10.1016/j.bbrc.2014.08.131	2015	Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.	MYB
25231743	10.1038/leu.2014.276	2015	MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia.	MYB
25325875	10.3109/08820538.2014.959196	2015	Avoiding the major complication of ophthalmic pathology: misdiagnosis. A review of three common diagnostic challenges.	MYB
25336632	10.1182/blood-2014-05-576470	2015	Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.	MYB
25406379	10.1126/scisignal.2005500	2015	Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia.	MYB
25541152	10.1038/leu.2014.351	2015	MicroRNAs in B-cell lymphomas: how a complex biology gets more complex.	MYB
25948224	10.7534/j.issn.1009-2137.2015.02.051	2015	[Research Progress on Expression Regulation, Function and Clinical Significance of CASP8AP2 Gene].	MYB
23521217	10.1111/cas.12156	2014	Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.	MYB
23665184	10.1016/j.jhep.2013.04.031	2014	Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.	MYB
23910958	10.1016/j.bcmd.2013.07.003	2014	GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.	MYB
23963825	10.1002/ajh.23570	2014	Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.	MYB
24149102	10.1038/ncomms3549	2014	Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.	MYB
24424791	10.1002/pbc.24803	2014	Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols.	MYB
24586197	10.1371/journal.pgen.1004167	2014	Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis.	MYB
24613688	10.1016/j.yexmp.2014.02.015	2014	Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.	MYB
25394790	10.1126/science.1259037	2014	Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.	MYB
23098454	10.7314/apjcp.2012.13.8.3681	2013	Transcription regulation network analysis of MCF7 breast cancer cells exposed to estradiol.	MYB
23098478	10.7314/apjcp.2012.13.8.3825	2013	Combined study of cytogenetics and fluorescence in situ hybridization (FISH) analysis in childhood acute lymphoblastic leukemia (ALL) in a tertiary cancer centre in South India.	MYB
23237561	10.1016/j.leukres.2012.11.009	2013	Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro.	MYB
23246696	10.1016/j.gene.2012.12.009	2013	Regulation of the MIR155 host gene in physiological and pathological processes.	MYB
23534754	10.7314/apjcp.2013.14.1.359	2013	Tax is involved in up-regulation of HMGB1 expression levels by interaction with C/EBP.	MYB
23698072	10.1038/jid.2013.188	2013	Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome.	MYB
23857984	10.1084/jem.20122516	2013	The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.	MYB
23868181	10.1002/path.4239	2013	Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.	MYB
21544432	10.3892/ijo.8.4.815	2012	Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells.	MYB
21931777	10.1371/journal.pone.0024617	2012	Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma.	MYB
21948191	10.1093/intimm/dxr078	2012	Transcriptional control of T-cell development.	MYB
22493372		2012	Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.	MYB
22516378	10.1016/j.mce.2012.03.024	2012	c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells.	MYB
22764095	10.1002/ajh.23283	2012	Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.	MYB
22829978	10.1038/bcj.2012.20	2012	Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells.	MYB
22897851	10.1016/j.ccr.2012.06.007	2012	Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.	MYB
20065082	10.3324/haematol.2009.010413	2011	Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.	MYB
21062812	10.1093/nar/gkq1043	2011	microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma.	MYB
21084380	10.1210/me.2010-0249	2011	A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells.	MYB
21252985	10.1038/leu.2010.317	2011	In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels.	MYB
21314486	10.3109/10428194.2010.551158	2011	c-myc rearrangement in B-cell lymphoblastic lymphoma with the involvement of multiple extranodal lesions.	MYB
21339739	10.1038/onc.2011.12	2011	Prdm14 initiates lymphoblastic leukemia after expanding a population of cells resembling common lymphoid progenitors.	MYB
21460242	10.1182/blood-2010-10-312231	2011	Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1.	MYB
21772954	10.4081/pr.2011.e17	2011	Recent advances in β-thalassemias.	MYB
21853052	10.1371/journal.pone.0022880	2011	Single molecule analysis of c-myb alternative splicing reveals novel classifiers for precursor B-ALL.	MYB
20680360	10.1007/s00705-010-0777-y	2010	Marek's disease virus microRNA designated Mdv1-pre-miR-M4 targets both cellular and viral genes.	MYB
20726440		2010	Identification and characterization of novel oncogenes in chronic eosinophilic leukemia and T-cell acute lymphoblastic leukemia.	MYB
20800819	10.1016/S1877-1173(10)92006-1	2010	Early T cell differentiation lessons from T-cell acute lymphoblastic leukemia.	MYB
20831260	10.1021/bi1007723	2010	Use of recombinant cell-permeable small peptides to modulate glucocorticoid sensitivity of acute lymphoblastic leukemia cells.	MYB
18799215	10.1016/j.leukres.2008.07.030	2009	Double minute chromosomes containing MYB gene and NUP214-ABL1 fusion gene in T-cell leukemia detected by single nucleotide polymorphism DNA microarray and fluorescence in situ hybridization.	MYB
19349957	10.1038/labinvest.2009.26	2009	miRNA profiling of B-cell subsets: specific miRNA profile for germinal center B cells with variation between centroblasts and centrocytes.	MYB
19374191	10.2222/jsv.58.125	2009	[CCR4, HTLV-1 infection, and ATL oncogenesis].	MYB
19389505	10.1016/j.cancergencyto.2009.01.002	2009	High-resolution genomic profiling of pediatric lymphoblastic lymphomas reveals subtle differences with pediatric acute lymphoblastic leukemias in the B-lineage.	MYB
19841262	10.1073/pnas.0909114106	2009	Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.	MYB
17435759	10.1038/ng2025	2008	Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia.	MYB
18024587	10.1073/pnas.0709173104	2008	Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas.	MYB
18033314	10.1038/sj.leu.2405044	2008	Sézary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3.	MYB
18070937	10.1084/jem.20071637	2008	Alu elements mediate MYB gene tandem duplication in human T-ALL.	MYB
18071306	10.1038/sj.onc.1210984	2008	Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.	MYB
18093978	10.1074/jbc.M706307200	2008	Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modification.	MYB
18313764	10.1016/j.vetimm.2008.01.019	2008	Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis.	MYB
18337761	10.1038/leu.2008.57	2008	HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.	MYB
15921375		2007	Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).	MYB
17317889		2007	[Mean level of expression of c-myb gene in leukaemia of children].	MYB
17452517	10.1182/blood-2006-12-064683	2007	The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children.	MYB
17659053	10.1111/j.1365-2141.2007.06697.x	2007	In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.	MYB
17934490	10.1038/sj.onc.1210766	2007	Mechanisms of transcription factor deregulation in lymphoid cell transformation.	MYB
15507152	10.1186/1743-422X-1-3	2006	Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.	MYB
15986398	10.1002/cncr.21307	2006	Cytologic diagnosis of Burkitt lymphoma.	MYB
16341039	10.1038/sj.leu.2404059	2006	Genome-wide approach to identify risk factors for therapy-related myeloid leukemia.	MYB
16675958	10.1038/sj.emboj.7601106	2006	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	MYB
15578683	10.1002/cncr.20773	2005	Richter syndrome: biology, incidence, and therapeutic strategies.	MYB
15747776	10.1191/0748233703th185oa	2005	Dose-dependent transcriptome changes by metal ores on a human acute lymphoblastic leukemia cell line.	MYB
16029452	10.1111/j.1365-2141.2005.05594.x	2005	Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.	MYB
16088151	10.1159/000086434	2005	Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.	MYB
16239949	10.7150/ijms.2.122	2005	Differential gene expression in HIV/SIV-associated and spontaneous lymphomas.	MYB
15125232		2004	[Analysis of expression of a series of lymphoma-specific genes in human fibroblasts immortalized by SV40 virus].	MYB
12502821	10.1128/jvi.77.2.1059-1068.2003	2003	Long-range effects of retroviral insertion on c-myb: overexpression may be obscured by silencing during tumor growth in vitro.	MYB
12525640	10.1128/jvi.77.3.2056-2062.2003	2003	Genome-based identification of cancer genes by proviral tagging in mouse retrovirus-induced T-cell lymphomas.	MYB
12592394	10.1038/sj.onc.1206070	2003	Functional genomic analysis reveals distinct neoplastic phenotypes associated with c-myb mutation in the bursa of Fabricius.	MYB
12605034	10.1097/00019606-200303000-00005	2003	Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV.	MYB
12915553	10.1128/jvi.77.17.9378-9387.2003	2003	Silent point mutation in an avian retrovirus RNA processing element promotes c-myb-associated short-latency lymphomas.	MYB
12970736	10.1038/sj.onc.1206639	2003	Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.	MYB
11694351	10.1016/s0303-7207(01)00585-8	2002	Prolactin, interleukin-2 and FGF-2 stimulate expression, nuclear distribution and DNA-binding of rat homolog of pombe Cdc5 in Nb2 T lymphoma cells.	MYB
12147717	10.1136/mp.55.4.262	2002	Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.	MYB
11319807	10.1002/gcc.1133	2001	Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping.	MYB
11675351	10.1182/blood.v98.9.2778	2001	Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells.	MYB
11683956	10.1046/j.1365-2567.2001.01298.x	2001	Extinction of expression of the genes encoding haematopoietic cell-restricted transcription factors in T-lymphoma x fibroblast cell hybrids.	MYB
11713794		2001	Oligonucleotide therapeutics: clothing the emperor.	MYB
10692454	10.1074/jbc.275.9.6499	2000	A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cells.	MYB
10806999	10.1016/s0167-4781(99)00142-6	2000	Oligonucleotide therapeutics for hematologic disorders.	MYB
10815807	10.1038/sj.onc.1203536	2000	HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.	MYB
10910917		2000	A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation.	MYB
10037024	10.3109/10428199909167387	1999	Diagnosis of acute basophilic leukemia.	MYB
10221509	10.3109/10428199909058429	1999	Expression of c-myb and B-myb oncogenes on myelofibrotic marrow fibroblasts.	MYB
10380886	10.1038/sj.onc.1202956	1999	Cooperation of Myb and Myc proteins in T cell lymphomagenesis.	MYB
10390076		1999	Antisense strategy in hematological malignancies.	MYB
9409529	10.1292/jvms.59.1071	1998	Instability of the 12-nucleotide repeat in c-myb gene of bovine T-lymphoma cells.	MYB
9510180		1998	The A-Myb transcription factor is a marker of centroblasts in vivo.	MYB
9694711		1998	Bcl-3 expression and nuclear translocation are induced by granulocyte-macrophage colony-stimulating factor and erythropoietin in proliferating human erythroid precursors.	MYB
9713961	10.3109/10428199809057542	1998	Changes in oncogene expression implicated in evolution of chronic granulocytic leukemia from its chronic phase to acceleration.	MYB
8741261	10.1292/jvms.58.305	1997	Potential transforming-ability by internal deletion of the bovine c-myb gene.	MYB
8921366	10.1006/geno.1996.0516	1997	The B-lymphocyte maturation promoting transcription factor BLIMP1/PRDI-BF1 maps to D6S447 on human chromosome 6q21-q22.1 and the syntenic region of mouse chromosome 10.	MYB
8950988		1997	T-cell lymphomas in v-Myb transgenic mice.	MYB
8995644	10.1128/JVI.71.2.1213-1219.1997	1997	Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3.	MYB
8996698	10.1292/jvms.58.12_1169	1997	The proto-oncogene c-myb is expressed in sporadic bovine lymphoma, but not in enzootic bovine leukosis.	MYB
9190893	10.1038/sj.onc.1201130	1997	Deletion of c-myb exon 9 induced by insertion of repeats.	MYB
9192779		1997	GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter.	MYB
9209336		1997	Rapid induction of B-cell lymphomas by avian leukosis virus.	MYB
9210395	10.1042/bj3240729	1997	Regulatory domains of the A-Myb transcription factor and its interaction with the CBP/p300 adaptor molecules.	MYB
9250811	10.3109/10428199709039028	1997	CD11c integrin gene promoter activity during myeloid differentiation.	MYB
9261372	10.1128/JVI.71.9.6526-6533.1997	1997	Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma.	MYB
9261373	10.1128/JVI.71.9.6534-6540.1997	1997	Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus.	MYB
9312094	10.1074/jbc.272.40.24921	1997	The DNA binding domain of the A-MYB transcription factor is responsible for its B cell-specific activity and binds to a B cell 110-kDa nuclear protein.	MYB
9322889	10.3109/10428199709051776	1997	The A-myb transcription factor in neoplastic and normal B cells.	MYB
8634438		1996	Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias.	MYB
8683983	10.1016/0145-2126(96)00012-4	1996	c-myb intron I protein binding and association with transcriptional activity in leukemic cells.	MYB
8892859	10.1128/JVI.70.11.7414-7423.1996	1996	Retroviral insertional activation of the c-myb proto-oncogene in a Marek's disease T-lymphoma cell line.	MYB
7579338		1995	Granulocyte-macrophage colony-stimulating factor, phorbol ester, and sodium butyrate induce the CD11c integrin gene promoter activity during myeloid cell differentiation.	MYB
7609084	10.1128/JVI.69.8.5138-5141.1995	1995	Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas.	MYB
7630637		1995	Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.	MYB
7706314	10.1074/jbc.270.13.7661	1995	Members of the nuclear factor kappa B family transactivate the murine c-myb gene.	MYB
7876344	10.1242/jcs.107.10.2761	1995	The role of duplication of tumour-derived chromosome 15 carrying the rearranged pvt-1 gene in the transformed phenotype of YACUT T-cell lymphoma x G4 T-cell line somatic cell hybrids in dictating the terminal differentiation program of the parental G4 cell.	MYB
7504543	10.3109/10428199309047876	1994	Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia.	MYB
7516155	10.1006/bbrc.1994.1801	1994	Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression.	MYB
7929419		1994	A spontaneous internal deletion of the c-myb protooncogene enhances transcriptional activation in bovine T lymphoma cells.	MYB
8021494		1994	The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.	MYB
8039161	10.1016/0165-4608(94)90212-7	1994	Characterization of a rearrangement in the c-MYB promoter in the acute lymphoblastic leukemia cell line CCRF-CEM.	MYB
8116930		1994	Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.	MYB
8172818	10.1093/annonc/5.suppl_1.s51	1994	Chromosome analysis of non-Hodgkin's lymphomas by fluorescence in situ hybridization.	MYB
8265096	10.1159/000227302	1994	Amplification of the c-myc proto-oncogene in soft tissue sarcomas.	MYB
1485535	10.18926/AMO/32636	1993	Detection of oncogene rearrangements in human non-Hodgkin's lymphomas.	MYB
8101872	10.1002/jor.1100110410	1993	Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.	MYB
8391616		1993	Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T-, non-B-cell leukemias.	MYB
8474446	10.1128/mcb.13.5.2858-2869.1993	1993	Mechanism of c-myc regulation by c-Myb in different cell lineages.	MYB
1309260	10.1128/JVI.66.1.512-523.1992	1992	Activation of the c-myb locus is insufficient for the rapid induction of disseminated avian B-cell lymphoma.	MYB
1373069	10.3109/08880019209006397	1992	Oncogene RNA expression in three human lymphoblastic leukemia cell lines lymphocytes.	MYB
1560675	10.1016/0145-2126(92)90064-e	1992	Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis.	MYB
1630821		1992	Large-scale molecular mapping of human c-myb locus: c-myb proto-oncogene is not involved in 6q- abnormalities of lymphoid tumors.	MYB
1730880		1992	Constitutive versus cell cycle regulation of c-myb mRNA expression correlates with developmental stages in murine B lymphoid tumors.	MYB
1679639	10.1007/BF00176755	1991	Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.	MYB
1713508		1991	Differentiation in B-precursor acute lymphoblastic leukemia cell populations with CD34-positive subpopulations.	MYB
1829952	10.1038/bjc.1991.189	1991	Oncogenes in human testicular cancer: DNA and RNA studies.	MYB
1886709		1991	Loss of myb expression in an aggressive SJL/J B-cell lymphoma.	MYB
1907096	10.1002/ajh.2830370402	1991	Enhanced expression of poly(ADP-ribose) synthetase gene in malignant lymphoma.	MYB
1981333	10.3109/07357909009018928	1991	Chromosomal translocation t(1;22) and sis oncogene variant with gene amplification in a case of atypical malignant lymphoma.	MYB
1992438		1991	Two c-myb proteins differing by their aminotermini exhibit different transcriptional transactivation activities (yeast/reporter-effector system).	MYB
2065336		1991	Chromosome locations of the MYB related genes, AMYB and BMYB.	MYB
2577338		1991	Regulation of expression and transforming ability of the c-erbB-2 gene.	MYB
1695700	10.1016/0145-2126(90)90007-v	1990	A coordinated proto-oncogene expression characterizes MCF 247 murine leukemia virus-induced T-cell lymphomas irrespectively of proviral insertion affecting myc loci.	MYB
2144164	10.1016/0277-5379(90)90130-l	1990	Differential expression of the oncoproteins c-myc and c-myb in human lymphoproliferative disorders.	MYB
2189045	10.1016/0145-2126(90)90028-8	1990	p75c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation.	MYB
2204478	10.1016/0165-4608(90)90125-t	1990	c-myb gene analysis in T-cell malignancies with del(6q).	MYB
2224864		1990	Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients.	MYB
2574989	10.1038/bjc.1989.382	1990	Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.	MYB
2685565	10.1128/mcb.9.12.5456-5463.1989	1990	A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5'-disrupted myb loci.	MYB
2463898	10.1007/978-3-642-74006-0_43	1989	Sense and anti-sense transcription in the murine c-myb attenuator region.	MYB
2501514	10.1128/JVI.63.8.3220-3226.1989	1989	Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.	MYB
2526666		1989	Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.	MYB
2535727	10.1128/JVI.63.1.205-215.1989	1989	Properties of a murine retroviral recombinant of avian acute leukemia virus E26: a murine fibroblast assay for v-ets function.	MYB
2538646	10.1128/JVI.63.4.1630-1640.1989	1989	RAV-1 insertional mutagenesis: disruption of the c-myb locus and development of avian B-cell lymphomas.	MYB
2543645	10.1002/ijc.2910430627	1989	Retrovirally induced murine B-cell tumors rarely show proviral integration in sites common in T-cell tumors.	MYB
2548084	10.1128/mcb.9.6.2657-2664.1989	1989	Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: evidence for stage-specific events.	MYB
2550801	10.1128/mcb.9.9.3771-3776.1989	1989	Hematopoietic lineage-specific heterogeneity in the 5'-terminal region of the chicken proto-myb transcript.	MYB
2678098	10.1073/pnas.86.19.7326	1989	Differential binding of nuclear factors to the intron 1 sequences containing the transcriptional pause site correlates with c-myb expression.	MYB
2680541	10.1016/0014-4827(89)90036-0	1989	Distribution of c-myc, c-myb, and Ki-67 antigens in interphase and mitotic human cells evidenced by immunofluorescence staining technique.	MYB
3060791		1989	Nuclear and cytoplasmic distribution of cellular myb protein in human haematopoietic cells evidenced by monoclonal antibody.	MYB
3075608		1989	Aberrant expression of the K-ras proto-oncogene in B-cell malignancies.	MYB
3264606		1989	Expression of oncogenes in normal and transformed murine B lymphocytes.	MYB
3505665		1989	Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains.	MYB
2452755	10.1016/0014-5793(88)80422-8	1988	Organization of 5'-proximal c-myb exons in chicken DNA. Implications for c-myb tissue-specific transcription.	MYB
2828679	10.1128/JVI.62.3.839-846.1988	1988	Comparative molecular genetic analysis of lymphomas from six inbred mouse strains.	MYB
2831403	10.1128/JVI.62.4.1423-1432.1988	1988	Rapid induction of B-cell lymphomas: insertional activation of c-myb by avian leukosis virus.	MYB
3043180	10.1128/mcb.8.6.2504-2512.1988	1988	c-myc and c-myb protein degradation: effect of metabolic inhibitors and heat shock.	MYB
3316389		1988	Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors.	MYB
3469751	10.1126/science.3469751	1987	Relationship between the c-myb locus and the 6q-chromosomal aberration in leukemias and lymphomas.	MYB
3491735	10.1007/978-3-642-71562-4_22	1987	Structure and expression of c-myb protooncogene mRNA in murine B-cells.	MYB
3498214	10.1126/science.3498214	1987	Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation.	MYB
3008988		1986	Glucocorticoid inhibition of c-myc, c-myb, and c-Ki-ras expression in a mouse lymphoma cell line.	MYB
3016644	10.1093/nar/14.13.5309	1986	Structural organization and nucleotide sequence of mouse c-myb oncogene: activation in ABPL tumors is due to viral integration in an intron which results in the deletion of the 5' coding sequences.	MYB
2414915	10.1016/0042-6822(85)90310-1	1985	Oncogene expression in murine splenic T cells and in murine T-cell neoplasms.	MYB
3855567	10.1073/pnas.82.2.565	1985	Comparison of chemically induced and spontaneous murine thymic lymphomas in RF and AKR mice: differential expression of c-myc and c-myb.	MYB
4042463	10.1007/BF01758957	1985	Expression of abl and other oncogenes is independent of metastatic potential in Abelson virus-transformed malignant murine large cell lymphoma.	MYB
6090070	10.1007/978-3-642-69860-6_9	1984	Disruption and activation of the c-myb locus by M-MULV insertion in plasmacytoid lymphosarcomas induced by pristane and Abelson viruses.	MYB
6093260	10.1126/science.6093260	1984	Activation of the c-myb locus by viral insertional mutagenesis in plasmacytoid lymphosarcomas.	MYB
6329934	10.1002/hon.2900010108	1984	Characterization of the expression of cellular retrovirus genes and oncogenes in feline cells.	MYB
6462246	10.1038/310581a0	1984	Chromosomal localization of the human proto-oncogene c-ets.	MYB
6603429	10.1002/ijc.2910320208	1983	Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias.	MYB
6687762	10.1126/science.6687762	1983	DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas.	MYB
6954533	10.1073/pnas.79.7.2194	1982	Differential expression of the amv gene in human hematopoietic cells.	MYB
